TriSalus Life Sciences Inc (TLSI)

5.31 -0.14%

TriSalus Life Sciences Inc (TLSI) is currently trading at $5.31. This represents a loss of 0.14% from the previous session. With a market capitalization of $0.32B, TLSI is a key component of the Health Care sector. Investors looking to trade TLSI should compare margin rates and options platforms to optimize their portfolio management.

Broker Promotion
Get 15 Free Stocks on Moomoo → T&Cs Apply. Trade TLSI commission-free.
Trading Platform Comparison
Moomoo
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Good for small traders
IBKR
  • Min Deposit: $0
  • Commissions: $0–$0.005/share
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Professional-level tools
Ameritrade
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Strong research tools
Webull
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Easy mobile app
AI Market Sentiment

As of today, TriSalus Life Sciences Inc (TLSI) shows a bearish trend. Analysts are watching the 5.38 level closely.

Fundamentals
Mkt Cap0.32B
P/E Ratio0.0000
Volume27,493
Others Watching (By Market Cap)
SLS
Sellas Life Sci $4.57
-3.69% MDXG
MiMedx Group In $5.24
-2.15% BFLY
Butterfly Netwo $3.04
+2.88% TALK
Talkspace Inc $4.54
+0.75% PSNL
Personalis Inc $8.49
+2.41%
60-Day Technical Chart
Advanced Charting

Need more indicators for TLSI? Use the world's #1 platform.

Open TLSI on TradingView →
Charting Platforms
TradingView

Advanced charts & indicators, web & mobile

StockCharts

Technical analysis charts with overlays & indicators

BarCharts

Market data, charts, and technical signals

Finviz

Visual stock charts & heatmaps

Yahoo Finance Charts

Basic interactive charts with indicators

Side-by-Side: Stocks Near $5
Metric TLSI
-0.14% 		LRMR
+56.78% 		OPEN
-2.15% 		NIO
-1.60%
Price $5.31 $5.79 $5.00 $5.22
Mkt Cap $0.32B $0.48B $4.78B $12.76B
- View → View → View →
Latest Headlines
Insider Purchase: Chief Financial Officer of $TLSI Buys 3,657 Shares Quiver Quantitative • Feb 23, 2026 Cancer-focused medical tech firm TriSalus raises $40M at $4.10 a share Stock Titan • Feb 20, 2026 40-year healthcare dealmaker joins cancer-tech firm TriSalus board Stock Titan • Feb 9, 2026 TriSalus Leadership Makes Bold Insider Move Signaling Strong Confidence TipRanks • Feb 24, 2026 TriSalus Life Sciences (NASDAQ: TLSI) sets results call for Nov 13 at 4:30 p.m. ET Stock Titan • Oct 30, 2025
● Gemini Agentic AI Analyst Insight for TLSI
Market Education
View All Articles →
External Research